Advisornet Financial’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9K | Buy |
4,884
+616
| +14% | +$1.63K | ﹤0.01% | 1385 |
|
|
2025
Q1 | $12.8K | Buy |
4,268
+2,125
| +99% | +$6.4K | ﹤0.01% | 1317 |
|
|
2024
Q4 | $5.49K | Sell |
2,143
-750
| -26% | -$1.92K | ﹤0.01% | 1438 |
|
|
2024
Q3 | $10.8K | Hold |
2,893
| – | – | ﹤0.01% | 1384 |
|
|
2024
Q2 | $18.3K | Hold |
2,893
| – | – | ﹤0.01% | 1110 |
|
|
2024
Q1 | $15.5K | Buy |
2,893
+2,143
| +286% | +$11.5K | ﹤0.01% | 1153 |
|
|
2023
Q4 | $3.77K | Hold |
750
| – | – | ﹤0.01% | 1551 |
|
|
2023
Q3 | $1.27K | Hold |
750
| – | – | ﹤0.01% | 1751 |
|
|
2023
Q2 | $2.09K | Hold |
750
| – | – | ﹤0.01% | 1706 |
|
|
2023
Q1 | $1.37K | Sell |
750
-4
| -0.5% | -$7 | ﹤0.01% | 1803 |
|
|
2022
Q4 | $3.82K | Buy |
754
+4
| +0.5% | +$20 | ﹤0.01% | 1526 |
|
|
2022
Q3 | $4K | Hold |
750
| – | – | ﹤0.01% | 1528 |
|
|
2022
Q2 | $3K | Hold |
750
| – | – | ﹤0.01% | 1603 |
|
|
2022
Q1 | $4K | Buy |
750
+500
| +200% | +$2.67K | ﹤0.01% | 1650 |
|
|
2021
Q4 | $2K | Hold |
250
| – | – | ﹤0.01% | 1798 |
|
|
2021
Q3 | $2K | Hold |
250
| – | – | ﹤0.01% | 1740 |
|
|
2021
Q2 | $4K | Hold |
250
| – | – | ﹤0.01% | 1589 |
|
|
2021
Q1 | $6K | Buy |
+250
| New | +$6K | ﹤0.01% | 1460 |
|